These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9416546)

  • 1. The safety and efficiency of immunotherapy.
    Alvarez-Cuesta E; Hernández Peña J
    J Investig Allergol Clin Immunol; 1997; 7(5):358-9. PubMed ID: 9416546
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
    Ibáñez Sendín MD
    Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The position of immunotherapy in the European Academy of Allergology and Clinical Immunology.
    Malling HJ
    J Investig Allergol Clin Immunol; 1997; 7(5):356-7. PubMed ID: 9416545
    [No Abstract]   [Full Text] [Related]  

  • 4. Rush injection therapy for asthma and allergic rhinitis.
    Greenberger PA
    Ann Allergy; 1994 Nov; 73(5):378-80. PubMed ID: 7978528
    [No Abstract]   [Full Text] [Related]  

  • 5. Sublingual immunotherapy for asthma: need for high quality meta-analyses to prove the concept.
    Larenas-Linnemann DE; Cox LS
    Allergy; 2007 Jun; 62(6):704-5; author reply 706-7. PubMed ID: 17419686
    [No Abstract]   [Full Text] [Related]  

  • 6. Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases.
    Malling HJ; Bousquet J
    Clin Allergy Immunol; 2008; 21():343-58. PubMed ID: 18828516
    [No Abstract]   [Full Text] [Related]  

  • 7. Pro: Immunotherapy is clinically indicated in the management of allergic asthma.
    Bousquet J
    Am J Respir Crit Care Med; 2001 Dec; 164(12):2139-40; discussion 2141-2. PubMed ID: 11751174
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of therapy of respiratory allergies with microbial antigen complex].
    Dobiásová L; Dolezalová K; Riglová J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1968; 11(5):647-54. PubMed ID: 5257727
    [No Abstract]   [Full Text] [Related]  

  • 9. Con: Immunotherapy is not clinically indicated in the management of allergic asthma.
    Adkinson NF
    Am J Respir Crit Care Med; 2001 Dec; 164(12):2140-1; discussion 2141-2. PubMed ID: 11751175
    [No Abstract]   [Full Text] [Related]  

  • 10. [Specific immunotherapy: indications and contraindications].
    Reinhardt MC
    Rev Med Suisse Romande; 1994 Mar; 114(3):233-43. PubMed ID: 8171233
    [No Abstract]   [Full Text] [Related]  

  • 11. Desensitization therapy for asthma in allergic children.
    Johnson KH; Millard PS
    J Fam Pract; 1997 May; 44(5):439-40. PubMed ID: 9152253
    [No Abstract]   [Full Text] [Related]  

  • 12. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized clinical trials.
    Bousquet J; Michel FB; Malling HJ
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1737-8. PubMed ID: 7582321
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children.
    Kuna P; Kaczmarek J; Kupczyk M
    J Allergy Clin Immunol; 2011 Feb; 127(2):502-508.e1-6. PubMed ID: 21281874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific immunotherapy in children is safe and effective.
    Cantani A; Arcese G; Gagliesi D; Lucenti P
    Eur Rev Med Pharmacol Sci; 1998; 2(1):41-4. PubMed ID: 9825570
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma.
    Massanari M; Nelson H; Casale T; Busse W; Kianifard F; Geba GP; Zeldin RK
    J Allergy Clin Immunol; 2010 Feb; 125(2):383-9. PubMed ID: 20159249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical results obtained in bronchial asthma and other allergic situations by means of desensitization with a non-specific polyvalent vaccine].
    da FONSECA C
    J Med (Oporto); 1961 Oct; 46():325-34. PubMed ID: 13893910
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of pretreatment cost-effectiveness and side effects of omalizumab versus prednisone/montelukast on tolerability of immunotherapy.
    Rosenberg JL
    J Allergy Clin Immunol; 2011 Feb; 127(2):548; author reply 548-9. PubMed ID: 21281877
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of sublingual immunotherapy.
    Passalacqua G; Guerra L; Pasquali M; Lombardi C; Canonica GW
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):3-12; quiz 12-3, 103. PubMed ID: 15281466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for atopic disease.
    Lieberman P; Patterson R
    Adv Intern Med; 1974; 19():391-411. PubMed ID: 4131290
    [No Abstract]   [Full Text] [Related]  

  • 20. [Allergic asthma and specific desensitization].
    DURIEU H; DE CLERCQ F; PAYFA M; ROBIENCE Y
    Brux Med; 1961 Feb; 41():209-17. PubMed ID: 13725202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.